Creades AB Series A (0QI9) - Total Liabilities

Latest as of March 2026: Skr39.00 Million SEK ≈ $4.20 Million USD

Based on the latest financial reports, Creades AB Series A (0QI9) has total liabilities worth Skr39.00 Million SEK (≈ $4.20 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Creades AB Series A - Total Liabilities Trend (2012–2025)

This chart illustrates how Creades AB Series A's total liabilities have evolved over time, based on quarterly financial data. See Creades AB Series A (0QI9) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Creades AB Series A Competitors by Total Liabilities

The table below lists competitors of Creades AB Series A ranked by their total liabilities.

Company	Country	Total Liabilities
Smith Douglas Homes Corp. NYSE:SDHC	USA	$164.30 Million
Garuda Metalindo Tbk PT JK:BOLT	Indonesia	Rp581.39 Billion
Fine DNC Co. Ltd KQ:049120	Korea	₩53.07 Billion
T.A.C. Consumer Public Company Limited BK:TACC	Thailand	฿479.12 Million
UNICOMMERCE ESOLUTIONS LIMITED NSE:UNIECOM	India	Rs775.82 Million
Iceland Seafood International hf. IC:ICESEA	Iceland	Ikr166.12 Million
SYN prop e tech S.A. SA:SYNE3	Brazil	R$954.80 Million
Polaryx Therapeutics, Inc. Common Stock NASDAQ:PLYX	USA	$855.00K

Liability Composition Analysis (2012–2025)

This chart breaks down Creades AB Series A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Creades AB Series A.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	91.00	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.00	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Creades AB Series A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Creades AB Series A (2012–2025)

The table below shows the annual total liabilities of Creades AB Series A from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr93.00 Million ≈ $10.01 Million	-38.82%
2024-12-31	Skr152.00 Million ≈ $16.36 Million	+3.40%
2023-12-31	Skr147.00 Million ≈ $15.82 Million	-40.00%
2022-12-31	Skr245.00 Million ≈ $26.37 Million	-57.39%
2021-12-31	Skr575.00 Million ≈ $61.88 Million	+47.44%
2020-12-31	Skr390.00 Million ≈ $41.97 Million	+747.83%
2019-12-31	Skr46.00 Million ≈ $4.95 Million	+4500.00%
2018-12-31	Skr1.00 Million ≈ $107.62K	0.00%
2017-12-31	Skr1.00 Million ≈ $107.62K	0.00%
2016-12-31	Skr1.00 Million ≈ $107.62K	-99.49%
2015-12-31	Skr197.00 Million ≈ $21.20 Million	+74.34%
2014-12-31	Skr113.00 Million ≈ $12.16 Million	-28.48%
2013-12-31	Skr158.00 Million ≈ $17.00 Million	+154.84%
2012-12-31	Skr62.00 Million ≈ $6.67 Million	--

About Creades AB Series A

LSE:0QI9 UK

Market Cap

$108.46 Million

Skr1.01 Billion SEK

Market Cap Rank

#18973 Global

#110 in UK

Share Price

Skr80.85

Change (1 day)

+1.44%

52-Week Range

Skr64.45 - Skr82.45

All Time High

Skr141.61